Non Serious Adverse Drug Reactions Report

Start Date:2016-03-15 End Date:2016-03-17
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0126Subject Initials :RCMDOB :01/09/1989Sex:FemaleRace:AsianHeight:165cmWeight:60.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/21/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/07/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: the right fallopian tube obstruction, poor uterine shape Uk-Unk-2013Not on treatment/medication
Hysteroscopy: uterine spindle-shaped, single horn.Uk-Unk-2014Not on treatment/medication
 



16-MAR-16
NA/EMR700623-541/C02-0126
Page 1 of 76
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-03-15 End Date:2016-03-17
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0134Subject Initials :QYLDOB :06/17/1986Sex:FemaleRace:AsianHeight:155cmWeight:47.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/22/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/06/201506/12/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Laparotomy: pelvic abscess incision and drainage, the right accessories cystectomyUk-Unk-2009Not on treatment/medication
Hysteroscopy normal uterine shapeUk-Unk-2013Not on treatment/medication
Hysteroscopic curettageUk-Unk-2015Not on treatment/medication
 



16-MAR-16
NA/EMR700623-541/C02-0134
Page 2 of 76
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-03-15 End Date:2016-03-17
Study :EMR700623-541Investigator :NACountry of Investigator :KoreaSiteNo:K01
Subject No :k01-049Subject Initials :PGRDOB :02/20/1983Sex:FemaleRace:AsianHeight:168cmWeight:62kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/02/2015300
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/13/201505/29/2015RelatedMild
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableConcomitant medication **,Led to study terminationResolved
Event Description:albumin treatment and resloved
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
laparoscopic ovary cystectomyUK-UNK-2004Not on treatment/medication



15-MAR-16
NA/EMR700623-541/k01-049
Page 3 of76